• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Neuberger Berman High Yield Strategies

Neuberger Berman High Yield Strategies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1

    Alnylam Reports Positive Initial Results from Ongoing Phase 1/2 Study of ALN-GO1, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1

  2. Novacyt provides a business update

    Novacyt provides a business update

  3. WiFi SPARK appoints Tracy Scriven as Director of Healthcare UK

    WiFi SPARK appoints Tracy Scriven as Director of Healthcare UK

  4. Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress

    Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress

  5. HealthTap Launches a New Company in Great Britain

    HealthTap Launches a New Company in Great Britain

  6. Japan Equity CEFs Win the First Quarter

    These closed-end funds were unstoppable in early 2015; plus, did the first IPO of 2015 usher in a new era for CEF shareholders?

  7. Observations about Neuberger Berman Closed-End Fund Tender Offers

    Dan Plettner invests and receives income for securities research, including “buy-side” research. Dan licenses his own real time trading data to Covestor Ltd. (“Covestor”), frequently including positions discussed in his Morningstar Contributions. Covestor is a Registered Investment Advisor that ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.